In a study of over a million women, digital breast tomosynthesis (DBT) showed improved breast cancer screening outcomes over screening with standard digital mammography alone.
The CL-S1200 is a 30.9-inch color monitor with 12 megapixels for reporting medical images of various modalities such as CT, CR/DR, MR, ultrasound or mammography.
The risk of developing breast cancer is higher in breasts with high density. But why is that? Researchers at Linköping University have shown major biological differences that promote cancer growth.
Women with high-risk breast lesions (HRLs) and no family history of breast cancer or BRCA mutations are generally considered to be at moderate risk of developing breast cancer. Breast cancer screening guidelines suggest breast MRI be considered as a supplement to mammography. But is this expensive exam necessary?
Cancer – one word that turns the patients’ world upside down. In addition to uncertainty and fear, they often face an unnerving series of exams and treatments. With its new One-Stop Clinic concept, GE Healthcare now wants to help make this journey as smooth as possible. At a single location, in an environment designed for comfort, the patients undergo all necessary steps within a short period…
When double reading screening mammograms, radiographers trained for the task perform as well as radiologists in key areas, according to a new publication.
Patients with multiple architectural distortion (AD) identified on digital breast tomosynthesis may benefit from biopsy of all areas, given the variation of pathologic diagnoses across individuals.
Contrast-enhanced mammography (CEM) has gone a long way since it was first approved by the Food and Drug Administration (FDA) in 2011. An Italian expert explained how useful the modality has become in breast imaging in a dedicated course at ECR 2022.
Multiparametric ultrasound (MPUS) has proven its value in the abdomen – now, the technique is increasingly moving towards peripheral areas such as breast and testis imaging, experts showed in a dedicated session at ECR 2022.
Contrast-enhanced mammography (CEM) may be a useful alternative test for neoadjuvant therapy (NAT) response assessment in patients with breast cancer who are unable to undergo MRI.
A major new study shows that artificial intelligence (AI) is a promising tool for breast cancer detection in screening mammography programs.
A software based on deep learning with convolutional neural networks can accurately and consistently classify breast density on mammograms according to BI-RADS criteria.
Groundbreaking technologies have improved our ability to accurately diagnose breast cancer and reduce callbacks, focusing on compassionate care for patients as they move along their breast health journey.
When it comes to your patient’s health, certainty matters. Breast biopsies play a vital role in the continuum of care for women, providing insights into mass and calcification identification so you can make the best-informed decisions.
Fujifilm aims to become an entity that can contribute to the advancement of human health by supporting the ongoing transformation in the healthcare industry – as a “One-Stop” solution partner.
Artificial intelligence (AI) models that evaluate medical images have potential to speed up and improve accuracy of cancer diagnoses, but they may also be vulnerable to cyberattacks.
Mammograms are a safe, effective way to detect the presence of breast cancer in women. But doctors recommend most females should start getting mammograms after the age of 40 in part because the procedure involves small doses of ionizing radiation. While the risk of getting breast cancer is higher for older people, it can strike at any age. Studies show that 5% to 7% of females with breast cancer…
The breast imaging field plays a critical role in women’s health and wellbeing around the globe. Bringing together experts, leaders and innovators from across the breast imaging landscape, the 2021 European Society of Breast Imaging (EUSOBI) Congress comes at a crucial time and represents a pivotal opportunity for the industry as a whole. Taking place online from 4-28 October, 2021, the virtual…
New research indicates that MRIs are cost effective for detecting breast cancer for women with very dense breasts detected by mammography. About 10% of women have extremely dense breasts, and current mammography screening guidelines do not recommend additional imaging tests unless there is a strong family history or genetic risk for breast cancer. Such women face two problems. They have increased…
In an effort to promote access to professional breast imaging knowledge, the European Society of Radiology (ESR) now links to educational materials from DenseBreast-info.org as a resource for its members about the screening and risk implications of dense breast tissue.
In the emerging era of personalized medicine, risk-based breast cancer screening protocols may be better than the one-size-fits all approach. It’s time to consider adopting them, Jack Cuzick, Ph.D., said in the President’s Address of the 2021 Society of Breast Imaging/American College of Radiology Breast Imaging Symposium.
One of the negative impacts of the coronavirus pandemic has been the suspension or postponement of many cancer screening services. Each year, these services help prevent and detect the presence of cancer at an early stage; timely diagnosis and care are crucial in preventing the spread of cancer. The National Screening Observatory has confirmed this, reporting alarming statistics: during the first…
Fujifilm Europe GmbH is launching the new “Harmony” version of its Amulet Innovality mammography system. The “Harmony” version brings together improved diagnostic performance with new design themes to embellish and illuminate your mammography suite, creating an environment to put your patients at ease.
The pandemic has presented healthcare systems with new challenges, resulting in backlogs of routine screenings and delayed procedures which threaten the health and wellbeing of patients, as well as the ability of facilities to serve their communities. In order to address these widespread issues, we need to ensure that healthcare professionals are able to operate with precision, confidence and…
Medical technology company iCAD, Inc. announced that ProFound AI for 2D Mammography might notably reduce the risk of interval breast cancer, according to a new retrospective analysis. The aim of the study was to determine if adding AI to reading mammography as a supportive tool may help in decreasing the interval cancer rate in population-based organized mammography screening programs in Germany.
